Table 6 Main TAVI access-related complications and in hospital follow-up of the PS-Matched population.

Need for surgical closure

1

(0.6)

0

(0.0)

1

(1.2)

0.316

Perforation

6

(3.6)

2

(2.4)

4

(4.8)

0.406

Femoral artery occlusion

1

(0.6)

1

(1.2)

0

(0.0)

0.500

Pseudo-aneurysm

1

(0.6)

1

(1.2)

0

(0.0)

0.500

Retroperitoneal hematoma

0

(0.0)

0

(0.0)

0

(0.0)

-

Minor vasc. complications

8

(4.8)

3

(3.6)

5

(6.0)

0.469

Major vasc. complications

2

(1.2)

0

(0.0)

2

(2.4)

0.249

Cr after TAVI (higher value during first week)

1.3

± 0.9

1.4

± 0.7

1.7

± 1.7

0.138

AKI

33

(19.6)

14

(16.7)

19

(22.6)

0.332

AKI stage 1

28

(16.7)

14

(16.7)

14

(16.7)

1.000

AKI stages ≥ 2

5

(3.0)

0

(0.0)

5

(6.0)

0.029

Need for RBC transfusion (1–3 days after TAVI)

16

(9.5)

5

(6.0)

11

(13.1)

0.115

BARC type ≥ 3a bleeding

20

(11.9)

9

(10.7)

11

(13.1)

0.634

VARC-3 type ≥ 2 bleeding

12

(7.1)

2

(2.4)

10

(11.9)

0.016

Permanent PM implantation

41

(24.4)

18

(21.4)

23

(27.4)

0.369

Stroke/TIA

2

(1.2)

1

(1.2)

1

(1.2)

1.000

Death

1

(0.6)

1

(1.2)

0

(0.0)

0.500

Mean Hospitalization (TAVI to discharge) (days)

7.9

± 5.2

6.9

± 4.0

8.9

± 6.1

0.015

Pt. discharged ≤ 72 h after TAVI (n)

24

(14.4)

19

(22.9)

5

(6.0)

0.002